Tredje AP fonden Trims Stake in Henry Schein, Inc. (NASDAQ:HSIC)

Tredje AP fonden reduced its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 1.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,356 shares of the company’s stock after selling 319 shares during the period. Tredje AP fonden’s holdings in Henry Schein were worth $1,305,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Summit Securities Group LLC bought a new position in shares of Henry Schein in the 2nd quarter worth approximately $31,000. Beach Investment Counsel Inc. PA purchased a new position in Henry Schein during the second quarter valued at $37,000. Blue Trust Inc. lifted its position in Henry Schein by 104.2% during the second quarter. Blue Trust Inc. now owns 931 shares of the company’s stock valued at $60,000 after buying an additional 475 shares during the period. Mather Group LLC. purchased a new stake in shares of Henry Schein in the 1st quarter worth about $97,000. Finally, Palisade Asset Management LLC purchased a new stake in shares of Henry Schein in the 1st quarter worth about $113,000. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Henry Schein Price Performance

NASDAQ HSIC opened at $71.15 on Friday. Henry Schein, Inc. has a one year low of $60.01 and a one year high of $82.63. The stock has a 50-day moving average of $69.89 and a 200 day moving average of $70.38. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.90 and a current ratio of 1.55. The company has a market capitalization of $9.11 billion, a price-to-earnings ratio of 24.04, a PEG ratio of 1.88 and a beta of 0.86.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $1.23 EPS for the quarter, topping analysts’ consensus estimates of $1.22 by $0.01. The firm had revenue of $3.10 billion during the quarter, compared to analyst estimates of $3.27 billion. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The business’s revenue for the quarter was up .0% on a year-over-year basis. During the same period in the previous year, the business posted $1.31 earnings per share. On average, sell-side analysts forecast that Henry Schein, Inc. will post 4.75 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on HSIC shares. Piper Sandler restated an “overweight” rating and issued a $86.00 price objective on shares of Henry Schein in a report on Friday, June 21st. Baird R W upgraded Henry Schein from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 22nd. Robert W. Baird reduced their price objective on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research report on Wednesday, August 7th. Barrington Research reissued an “outperform” rating and issued a $82.00 target price on shares of Henry Schein in a report on Friday. Finally, Evercore ISI cut their target price on Henry Schein from $72.00 to $70.00 and set an “in-line” rating on the stock in a research note on Wednesday, August 7th. One analyst has rated the stock with a sell rating, six have assigned a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Henry Schein has a consensus rating of “Hold” and a consensus target price of $77.10.

Insider Activity

In related news, SVP Lorelei Mcglynn sold 21,035 shares of Henry Schein stock in a transaction on Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the sale, the senior vice president now owns 71,833 shares of the company’s stock, valued at $4,978,026.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.14% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.